Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

CRO/CMO Services

The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

Porton Biologics Raises $61 Million for Cell/Gene Therapy CDMO Services

StoneWise Raises $100 Million to Support AI Drug Development Services

Hangzhou Innoforce Raises $96 Million for CRO/CDMO Biopharma Services

WuXi Biologics Acquires 90% Stake in CBC's Suzhou CDMO

WuXi Biologics Buys Pfizer's Biologics Manufacturing Facility in Hangzhou

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021